Processing

Please wait...

Settings

Settings

Goto Application

1. WO2011036211 - POLYPEPTIDES AND NUCLEIC ACIDS FOR TREATING ERBB2-DEPENDENT CANCERS

Publication Number WO/2011/036211
Publication Date 31.03.2011
International Application No. PCT/EP2010/064055
International Filing Date 23.09.2010
IPC
C07K 14/47 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
14Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
435from animals; from humans
46from vertebrates
47from mammals
C07K 14/52 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
14Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
435from animals; from humans
52Cytokines; Lymphokines; Interferons
CPC
A61P 35/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
35Antineoplastic agents
C07K 14/47
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
14Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
435from animals; from humans
46from vertebrates
47from mammals
C07K 14/52
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
14Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
435from animals; from humans
52Cytokines; Lymphokines; Interferons
C07K 2319/00
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
2319Fusion polypeptide
Applicants
  • INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) [FR]/[FR] (AllExceptUS)
  • BOURDOULOUS, Sandrine [FR]/[FR] (UsOnly)
  • DJERBI-BOUILLIE, Rym [FR]/[FR] (UsOnly)
Inventors
  • BOURDOULOUS, Sandrine
  • DJERBI-BOUILLIE, Rym
Agents
  • BLOT, Philippe
Priority Data
09305884.023.09.2009EP
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) POLYPEPTIDES AND NUCLEIC ACIDS FOR TREATING ERBB2-DEPENDENT CANCERS
(FR) POLYPEPTIDES ET ACIDES NUCLÉIQUES POUR TRAITER DES CANCERS DÉPENDANTS DE L'ERBB2
Abstract
(EN)
The present invention relates to polypeptides, nucleic acids and pharmaceutical compositions suitable for use in the treatment of ErbB2 dependent-cancers, in particular of tumors overexpressing ErbB2 or expressing mutated forms of the ErbB2 gene.
(FR)
La présente invention concerne des polypeptides, acides nucléiques et compositions pharmaceutiques appropriées pour une utilisation dans le traitement de cancers dépendant de l'ERBB2, en particulier de tumeurs surexprimant ERBB2 ou de formes mutées d'expression du gène ErbB2.
Also published as
Latest bibliographic data on file with the International Bureau